Business
CSL confirms UQ vaccine production, trials set for December – Sydney Morning Herald
The blood plasma giant has sealed its deal with the Australian government, confirming it is ready to produce an Australian COVID-19 vaccine candidate if trials …
Blood plasma giant CSL has confirmed the deal with the Australian government to produce the University of Queensland’s COVID-19 vaccine has been sealed, with the next stage of trials planned to start in December.
The $132 billion biotech told investors on Thursday morning it had signed off on the final agreement to produce 51 million doses of the University of Queensland (UQ) vaccine , known as V451, if it is successful. It said first participants in the phase 2b/3 trials of the product would b…
-
Noosa News22 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General17 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General23 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General16 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues